Načítá se...
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis
Current B cell-directed therapies for multiple sclerosis impact multiple B cell functions. CD98hc enables B cell clonal expansion and antibody production. I probed the relative importance of autoantibody secretion vs. other B cell functions in MS and targeted CD98hc as a possible therapeutic strateg...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4152380/ https://ncbi.nlm.nih.gov/pubmed/25002078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2014.06.015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|